Although CXCL12 is subjected to more posttranslational than transcriptional regulation [196, 332, 333], cell- or tissue-type specific RNA isoforms may be the cause of some of the controversial or paradoxical effects of chemokine‒receptors on different signaling pathways in immune and cancer cells under specific microenvironments. Here, CXCL12 is linked to cancer.